4775-93-3

Basic information

• Product Name: 2,2'-DITHIODIPROPIONIC ACID
• Synonyms: 2,2'-DITHIODIPROPIONIC ACID;alpha,alpha'-Dithiodipropionic acid;2,2-Dithiopropionic acid;Dithiopropionicacid;2,2'-Dithiobispropionic acid;3-(2-carboxyethyldisulfanyl)propanoic acid;3-(2-carboxyethyldisulfanyl)propionic acid
• CAS NO: 4775-93-3
• Molecular Formula: C₆H₁₀O₄S₂
• Molecular Weight: 210.27
• Mol File: 4775-93-3.mol
• Article Data: 21

Chemical Properties

• Melting Point: 117.5 °C
• Boiling Point: 319.8°C (rough estimate)
• Flash Point: 214.5°C
• Appearance: /
• Density: 1.319 (estimate)
• Vapor Pressure: 6.64E-07mmHg at 25°C
• Refractive Index: 1.4950 (estimate)
• PKA: 3.14±0.10(Predicted)
• CAS DataBase Reference: 2,2'-DITHIODIPROPIONIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 2,2'-DITHIODIPROPIONIC ACID(4775-93-3)
• EPA Substance Registry System: 2,2'-DITHIODIPROPIONIC ACID(4775-93-3)

Safety Data

• Hazardous Substances Data: 4775-93-3(Hazardous Substances Data)

Usage

General Description

2,2'-dithiodipropionic acid is a unique type of chemical compound. Commonly known by the molecular formula C6H10O4S2, this substance possesses a distinct structure that includes two propionic acid groups linked by a pair of sulfur atoms. Its defining characteristic is its ability to form disulfide bonds, making it valuable in numerous applications across several industries. Commercially used in pharmaceuticals, personal care products, and the rubber industry, it offers vital properties such as antioxidant ability, curing, and adhesion. Despite its extensive use, caution should be exercised in its handling due to various health and environmental hazards.

InChI:InChI=1/C6H10O4S2/c1-3(5(7)8)11-12-4(2)6(9)10/h3-4H,1-2H3,(H,7,8)(H,9,10)

Upstream product

• 14618-66-7 2-methyl-3-thia-glutaric acid 
• 7732-18-5 water 
• 7726-95-6 bromine 
• 598-72-1 2-Bromopropionic acid 
• 79-42-5 2-mercaptopropanoic acid 
• 535-13-7 2-chloro-propanoic acid, ethyl ester 
• 33178-96-0 (R)-thiolactic acid 
• 7705-08-0 iron(III) chloride 
• 537-14-4 dichlorophenolindophenol 
• 124721-03-5 trans,trans,trans-[PtCl₂(OH)2(c-C₆H₁₁NH₂)(NH₃)] 
• 535-11-5 Ethyl 2-bromopropionate 
• 1206518-38-8 3-[(2S,3R)-4-hydroxy-3-methyl-1-phenylbutan-2-yl]-5-methylthiazolidine-2,4-dione 
• 1206518-34-4 3-[(2S,3S)-4-hydroxy-3-methyl-1-phenylbutan-2-yl]-5-methylthiazolidine-2,4-dione 
• 1206518-32-2 3-[(1S,2S)-3-hydroxy-2-methyl-1-phenylpropyl]-5-methyl-thiazolidine-2,4-dione 

Downstream Products

• 55306-57-5 2-sulfopropionic acid 
• 79-42-5 2-mercaptopropanoic acid 
• 922-52-1 L_g-threo-2,5-dimethyl-3,4-dithia-adipic acid 
• 21793-77-1 (+)-2,2'-dithiobispropionic acid 
• 20461-87-4 2-methyl-3-thiapentanoic acid 
• 127-17-3 2-oxo-propionic acid 
• 7783-06-4 hydrogen sulfide 
• 64-19-7 acetic acid 
• 15719-64-9 methylammonium carbonate 
• 1822-43-1 2,2'-disulfanediyl-bis-propionyl chloride 
• 1907-80-8 2-(1-diethylcarbamoyl-ethyldisulfanyl)-N,N-diethyl-propionamide 
• 1313496-30-8 C₁₄H₂₄N₂O₈S₂ 
• 1313496-26-2 C₁₄H₂₄N₂O₆S₂ 
• 1313496-28-4 C₁₈H₃₂N₂O₆S₂ 

Relevant articles and documents

METHODS OF TREAT1NG CANCER AND OTHER DISEASES

Disclosed are a method of treating cancer in a cell, a method of enhancing the chemotherapeutic treatment of a cancer treatment agent, a method of reducing resistance of a cancer cell to a chemotherapeutic agent, a method of reducing the amount or activity of an ABC-family mRNA and/or protein, a method of reducing the amount or activity of the ABCB1 mRNA and/or protein or the ABCC1 mRNA and/or protein in an animal cell undergoing cancer treatment, a method of reducing the amount or activity of glutathione and/or Bcl2 in the cancer cell, a method of treating other multidrug resistant diseases, and a method of treating a multidrug resistant cell such as a bacterial multidrug resistant Staphylococcus aureus (MRSA), tuberculosis, fungal infection, or MDR malaria, by administering a compound of the Formula (I): a diastereoisomer thereof, or a pharmaceutically acceptable salt thereof, wherein R1-R4 are as described herein. Also disclosed are pharmaceutical compositions comprising a compound of formula (I), a diastereoisomer thereof, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier

Rearrangement of oxazolidinethiones to thiazolidinediones or thiazinanediones and their application for the synthesis of chiral allylic ureas and α-methyl-β-amino acids

A novel rearrangement has been found between oxazolidinethiones and acyl halides under N-acylation reaction conditions to afford N-substituted 2,4-thiazolidinediones and N-substituted 1,3-thiazinane-2,4-diones. These heterocycles were used for the synthesis of chiral allylic ureas and α-methyl-β-amino acids.